Development of an Electro-Responsive Sorafenib-Loaded Polypyrrole Coating-Modified Nickel-Titanium Alloy for Tumor Ablation Therapy.

Lele Liu, Peng Gu, Dan Xia, Yonghao Wen, Baoe Li, Donghui Wang, Yaohong Wu

Abstract read

In one paragraph

Article in Journal of functional biomaterials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lele LiuHebei Key Laboratory of Biomaterials and Smart Theranostics, School of Health Sciences and Biomedical Engineering, Hebei University of Technology, Tianjin 300130, China.ORCID 0009-0002-2374-8559

Peng GuDepartment of Spine Surgery, Ganzhou People's Hospital, Ganzhou 341006, China.ORCID 0009-0008-2709-3485

Dan XiaTianjin Key Laboratory of Materials Laminating Fabrication and Interface Control Technology, School of Materials Science and Engineering, Hebei University of Technology, Tianjin 300130, China.ORCID 0000-0001-7892-7381

Yonghao WenDepartment of Spine Surgery, Ganzhou People's Hospital, Ganzhou 341006, China.

Baoe LiTianjin Key Laboratory of Materials Laminating Fabrication and Interface Control Technology, School of Materials Science and Engineering, Hebei University of Technology, Tianjin 300130, China.

Donghui WangHebei Key Laboratory of Biomaterials and Smart Theranostics, School of Health Sciences and Biomedical Engineering, Hebei University of Technology, Tianjin 300130, China.ORCID 0000-0002-1198-0978

Yaohong WuDepartment of Spine Surgery, Ganzhou People's Hospital, Ganzhou 341006, China.

Funding

National Natural Science Foundation of China 52271245Natural Science Foundation of Hebei Province C2026202004, H2022202007Natural Science Foundation of Tianjin 24JCYBJC01100

6 · The paper itself

Abstract

Nickel-titanium (NiTi) stents have been widely used for the palliative management of portal vein tumor thrombosis (PVTT) due to their excellent mechanical strength and biocompatibility. However, conventional NiTi implants are therapeutically passive and lack intrinsic antitumor activity, rendering them vulnerable to tumor ingrowth and subsequent restenosis. Electrical stimulation-mediated ablation offers a controllable physical strategy for local tumor clearance; however, the native TiO

Indexed as

electrically controlled drug releaseESnickel–titanium alloypolypyrrolesorafenibtumor ablation

Identifiers

PMID42646208

DOI10.3390/jfb17080405

PMCPMC13514127

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.